跳至主要内容
临床试验/JPRN-UMIN000036062
JPRN-UMIN000036062招募中未知

Controlled study for evaluation of the effect of AHCC(R) intake on eradication of high-risk type Human papillomavirus infection - A study for evaluation of AHCC(R) on eradication of Human papillomavirus

Hokkaido University Hospital0 个研究点目标入组 180 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25years-old 至 44years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • (a) Women diagnosed as having a histological diagnosis of Cervical Intraepithelial Neoplasia (CIN) grade 3 or worse, or who are in need of medical treatment (b) Women taking immuno suppressors such as steroids or biologics such as TNF-alpha (c) Women regularly taking immunostimulating supplements (d) Women with an uncontrolled progressive malignancy (e) Women suffering from any mental illness or mental symptoms which would make it difficult for them to participate in the study (f) Women who are unable to return for follow-up appointments. (g) Women who are or may be pregnant (h) Women who, for any other reason, are considered not suitable for participation by the investigators

研究者

相似试验